Clinical Research Directory
Browse clinical research sites, groups, and studies.
This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza
Sponsor: Traws Pharma, Inc.
Summary
This is an early-stage clinical trial to determine a safe and effective dose for Tivoxavir Marboxil (TRX-100) in patients with mild to moderate Influenza. Participants will take a study drug as well as a standard therapy. A descriptive statistics will be used to present the study results.
Official title: A Multicenter, Open-Label, Randomized Phase 2a Study to Evaluate the Safety and Efficacy of Different Oral Doses of TRX-100 and Standard of Care in Participants With Influenza
Key Details
Gender
All
Age Range
18 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
105
Start Date
2025-12-15
Completion Date
2027-01
Last Updated
2026-03-27
Healthy Volunteers
No
Conditions
Interventions
TRX-100
CEN inhibitor, dosage form - capsules, dosing regimen - QD
Standard of Care (SOC)
Standard of Care Influenza Antiviral therapy
Locations (1)
Novatrials
Charlestown, New South Wales, Australia